Primary Progression during Frontline CIT Associates with Decreased Efficacy of Subsequent CD 19 CAR-T Cell Therapy in LBCL.

Research output: Contribution to journal › Article › peer-review

Disciplines

@article{75c6418997f044348bcd9e1a3746bf1b,

title = "Primary Progression during Frontline CIT Associates with Decreased Efficacy of Subsequent CD 19 CAR-T Cell Therapy in LBCL.",

author = "\{Perez Perez\}, Ariel and \{and institutional affiliations\}, \{Additional authors\}",

note = "Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL",

year = "2022",

month = jul,

language = "American English",

journal = "Blood Advances",

}

TY - JOUR

T1 - Primary Progression during Frontline CIT Associates with Decreased Efficacy of Subsequent CD 19 CAR-T Cell Therapy in LBCL.

AU - Perez Perez, Ariel

AU - and institutional affiliations, Additional authors

N1 - Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL

PY - 2022/7

Y1 - 2022/7

UR - https://pubmed.ncbi.nlm.nih.gov/35816359/

M3 - Article

JO - Blood Advances

JF - Blood Advances

ER -